ARVN FY 2019 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena

ARVNArvinas, Inc.

$856M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$43M+200.0% YoY

Gross Profit

$43M100.0% margin

Operating Income

-$52M-119.9% margin

Net Income

-$70M-163.6% margin

EPS (Diluted)

$-1.89

Cash Flow

Operating Cash Flow

-$41M

Free Cash Flow

-$47M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$302M

Total Liabilities

$75M

Stockholders' Equity

$227M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$43M	$14M	+200.0%
Gross Profit	$43M	$14M	+200.0%
Operating Income	-$52M	-$44M	-17.6%
Net Income	-$70M	-$41M	-69.5%